Skip to main content

Table 3 Clinical outcome data for the HOPE Pilot study cohort

From: Behavioral health coaching for rural-living older adults with diabetes and depression: an open pilot of the HOPE Study

Data-Collection Timeframe

Outcome Measures

 

HbA1c

PHQ-9

PAID

Baseline, M (SD)

9.73 (2.62)

14.6 (2.99)

46.8 (6.29)

3-month, M (SD)

8.60 (3.56)

9.43 (3.91)

28.9 (15.6)

Change from baseline to 3-month, M (SD)

1.13 (1.70)

5.14 (2.27)

17.7 (10.7)

Effect Size, Cohen’s d

0.36

1.48

1.50

6-month, M (SD)

8.89 (3.35)

7.57 (5.03)

26.9 (25.9)

Change from baseline to 6-month, M (SD)

0.84 (1.62)

7.03 (4.43)

20.4 (20.7)

Effect Size, Cohen’s d

0.28

1.69

1.06

  1. M mean, SD standard deviation, R range;
  2. Effect sizes measured using Cohen’s d (0.8=large effect, 0.5=medium effect, 0.2=small effect).
  3. Baseline=readings at baseline assessment;
  4. 3-month=readings at 3-month follow-up assessment;
  5. 6-month=readings at 6-month follow-up assessment.
  6. HbA1c hemoglobin A1c; Lower HbA1c is consistent with better diabetes control.
  7. PHQ-9 Patient Health Questionnaire-9; Higher total PHQ-9 scores indicate elevated depressive symptoms.
  8. PAID Problem Areas In Diabetes scale; Higher total PAID scores represent greater diabetes related distress.